Streplink Pharmaceuticals Private Limited
About Streplink Pharmaceuticals Private Limited
Data last updated:
Streplink Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 08 September 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51101MH2015PTC268245. Its GSTIN is 24AAWCS1688K1ZJ (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Dipenkumar Kachhadiya and Rohit Bhimjibhai Gengadiya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹26.93 Lakh, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹65,975 (net margin 2.5%) and EBITDA of ₹84,469 (EBITDA margin 3.1%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 23% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Streplink Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address302 Gopi Krishna Nagar Chs Ltd Rawalpada S N Dube Road Near Mini Nagar School D, Ahisar (E), Mumbai, Maharashtra, India – 400068
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Streplink Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Streplink Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Streplink Pharmaceuticals Private Limited, buy the company report.
Financials of Streplink Pharmaceuticals Private Limited
FY 2025 filings availableStreplink Pharmaceuticals Private Limited reported revenue of ₹26.93 Lakh (up 28% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 28% growth in the latest year. EBITDA rose 112% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹84,469 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹65,975 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.1% | ||||
| Net Profit Margin | 2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Streplink Pharmaceuticals Private Limited, buy the company report.
Board of directors of Streplink Pharmaceuticals Private Limited
Streplink Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dipenkumar Kachhadiya | Director | 08 Sep 2015 | 11 Years 1 Months | Current |
| Rohit Bhimjibhai Gengadiya | Director | 06 Apr 2016 | 10 Years 6 Months | Current |
| Nileshkumar Amrutlal Makwana | Director | 08 Sep 2015 | 11 Years 1 Months | Current |
Auditor
Streplink Pharmaceuticals Private Limited is audited by HARESH DHADUK & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HARESH DHADUK & ASSOCIATES | FY 2017 | 148907 |
Shareholding
The shareholding of Streplink Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Streplink Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Streplink Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Streplink Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Streplink Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAWCS1688K1ZJ | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Streplink Pharmaceuticals Private Limited, buy the company report.
Recent activity
Streplink Pharmaceuticals Private Limited has 5 board changes on record since 2015: 3 appointments and 2 cessations. The latest: Kajalben Bhaveshbhai Vagadia ceased to be Additional Director on 19 Apr 2018.
Frequently asked questions
Streplink Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 08 September 2015 (11+ years old) and is registered under CIN U51101MH2015PTC268245.
Streplink Pharmaceuticals has 3 current directors:
- Dipenkumar Kachhadiya - Director
- Rohit Bhimjibhai Gengadiya - Director
- Nileshkumar Amrutlal Makwana - Director
The latest financial statements of Streplink Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Streplink Pharmaceuticals is 24AAWCS1688K1ZJ, registered in Gujarat.
The CIN (Corporate Identification Number) of Streplink Pharmaceuticals is U51101MH2015PTC268245. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Streplink Pharmaceuticals was incorporated on 08 September 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
Kajalben Bhaveshbhai Vagadia ceased to be Additional Director on 19 Apr 2018. Bhavesh Himmatbhai Vagadia ceased to be Director on 23 Jun 2017. Rohit Bhimjibhai Gengadiya was appointed as Director on 06 Apr 2016. Streplink Pharmaceuticals has 5 board changes on record in total.
The registered office of Streplink Pharmaceuticals is at 302 Gopi Krishna Nagar Chs Ltd Rawalpada S N Dube Road Near Mini Nagar School D, Ahisar E, Mumbai, Maharashtra, India – 400068.
Streplink Pharmaceuticals operates in the chemicals industry, in the medicinal chemical and botanical products segment.
The compliance status of Streplink Pharmaceuticals is compliant as of 12 July 2026. The company is actively filing with the Registrar of Companies.